COMPANY INFO
Cradle is a biotechnology company founded in 2021 by Jelle Prins and Stef Van Grieken, headquartered in Delft, Netherlands. It operates in the bioinformatics and chemoproteomics industry, employing 51-200 people, and its website is cradle.bio. Cradle uses AI and machine learning to design proteins, providing chemoproteomics solutions that accelerate protein design and development while ensuring secure intellectual property ownership for its clients.
Cradle is a biotechnology company founded in 2021 by Jelle Prins and Stef Van Grieken, headquartered in Delft, Netherlands. Operating within the bioinformatics and chemoproteomics industry, Cradle employs between 51 and 200 people. Leveraging AI and machine learning, Cradle specializes in designing proteins and providing chemoproteomics solutions to accelerate protein development, ensuring secure intellectual property ownership for its clients.
Cradle funding history demonstrates significant momentum in the biotechnology sector. The company has raised a total of $103 million across three funding rounds. Backed by prominent venture capital firms, Cradle funding rounds reflect a strategy focused on rapidly scaling AI-powered protein engineering capabilities, expanding research infrastructure, and growing the engineering and go-to-market teams. Key milestones include a substantial Series B round, validating their leadership in AI-driven protein design.
This Series B round was targeted at market expansion, scaling wet lab research capabilities, growing the engineering team, and broadening go-to-market operations to bring AI-powered protein engineering solutions to more laboratories worldwide.
The seed funding round enabled Cradle’s initial launch, focusing on the development of its AI-powered protein engineering platform and foundational team building.
No detailed public information is available regarding the Series A round.
IVP is a leading venture capital firm specializing in high-growth technology companies. As a key investor, IVP led Cradle’s Series B round, providing crucial support for the company’s market expansion and scaling efforts.
Index Ventures is a global venture capital firm with a strong track record in funding innovative tech and biotech startups. Index Ventures led Cradle’s seed round, supporting the company’s early development and technology validation.
Kindred Capital is an early-stage venture capital firm based in London, focused on backing exceptional founders. Kindred Capital co-led Cradle’s seed round, helping to establish its AI-driven protein engineering platform.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Cradle funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.